| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |